Despite demonstration of the superior outcomes of transcatheter aortic valve implantation (TAVI) versus optimal medical therapy for severe left ventricular systolic dysfunction, studies comparing TAVI and surgical aortic valve replacement (AVR) in this high-risk group have been lacking.We performed propensity matching for age, gender, baseline comorbidities, previous interventions, priority at hospital admission, frailty score, New York Heart Association class, EuroSCORE, and associated cardiac diseases. Next, the 30-day mortality and procedure-related morbidity of 162 patients (81 TAVI vs 81 AVR) with severe left ventricular systolic dysfunction (ejection fraction ≤ 35
作者:Francesco, Onorati;Paola, D'Errigo;Claudio, Grossi;Marco, Barbanti;Marco, Ranucci;Daniel Remo, Covello;Stefano, Rosato;Alice, Maraschini;Gennaro, Santoro;Corrado, Tamburino;Fulvia, Seccareccia;Francesco, Santini;Lorenzo, Menicanti
来源:The Journal of thoracic and cardiovascular surgery 2014 年 147卷 2期